Do not order based on the image alone. The image displayed may not represent the specific product you are ordering.
Abbott Nutrition Similac Pro-Advance 20 Infant Formula with Iron, 2 fl oz. (67323)
Abbott Nutrition Similac® Pro-Advance® 20 Infant Formula with Iron, 2 fl oz.
- A 20 Cal/fl oz, nutritionally complete, non-GMO,† milk-based, iron-fortified standard infant formula designed to support both immune and cognitive development with key ingredients found in breast milk. For use as a supplement or alternative to breastfeeding.
- Nucleotides to help support the developing immune system.2,3
- No artificial growth hormones.‡
- OptiGRO® is our exclusive blend of DHA, lutein and vitamin E: these important ingredients are found in breast milk.
- DHA for brain and eye development.
- Lutein to support eye health.
- Vitamin E, an important nutrient to support developing cells.
- Our exclusive formula has:
- Calcium for strong bones - no palm olein oil.
- Prebiotics to help promote digestive health.
- Carotenoids like those naturally found in breast milk.
- Clinically shown to support normal growth and tolerance in newborns.4,5
- Clinically shown to support greater calcium absorption§ for strong bones.6,7
- Not for infants or children with galactosemia.
- Never use a microwave oven to warm formula. Serious burns can result.
- Powdered infant formulas are not sterile and should not be fed to premature infants or infants who might have immune problems unless directed and supervised by your baby's doctor.
† Ingredients not genetically engineered.
2 Schaller JP, et al. Pediatr Res. 2004;56(6):883-890.
‡ No significant difference has been shown between milk derived from rbST-treated and non-rbST-treated cows.
3 Buck RH, et al. Pediatr Res. 2004;56(6):891-900.
§ Similac® with Iron vs Enfamil® with Iron. Enfamil is not a trademark of Abbott Laboratories.
4 Marriage B, et al. JPGN 2015;61:649-653.
5 Kajzer J, et al. FASEB J. 2016;30(Supp):671.4.
6 Nelson SE, et al. J Am Coll Nutr. 1998;17(4):327-332.
7 Koo W, et al. Pediatrics. 2003;111:1017-1023.